Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Other financing activities (2018 - 2020)

Standard Biotools has reported Other financing activities over the past 3 years, most recently at $18000.0 for Q2 2020.

  • Quarterly Other financing activities rose 20.0% to $18000.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $375000.0 through Jun 2021, down 25.45% year-over-year, with the annual reading at $12.5 million for FY2022, N/A changed from the prior year.
  • Other financing activities was $18000.0 for Q2 2020 at Standard Biotools, down from $357000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $2.6 million in Q2 2018 and troughed at $15000.0 in Q2 2019.
  • The 3-year median for Other financing activities is $98000.0 (2018), against an average of $420625.0.
  • Year-over-year, Other financing activities crashed 99.41% in 2019 and then grew 20.0% in 2020.
  • A 3-year view of Other financing activities shows it stood at $83000.0 in 2018, then skyrocketed by 36.14% to $113000.0 in 2019, then plummeted by 84.07% to $18000.0 in 2020.
  • Per Business Quant, the three most recent readings for LAB's Other financing activities are $18000.0 (Q2 2020), $357000.0 (Q1 2020), and $113000.0 (Q3 2019).